Glycol Chitosan-Docosahexaenoic Acid Liposomes for Drug Delivery: Synergistic Effect of Doxorubicin-Rapamycin in Drug-Resistant Breast Cancer

The use of chitosan-coated flexible liposomes as a remarkable carrier to enhance the antitumor efficacy of 5-fluorouracil against colorectal cancer

(2019) Abdullah Alomrani et al.   SAUDI PHARMACEUTICAL JOURNAL

Knockdown of lncRNA‑HOTAIR downregulates the drug‑resistance of breast cancer cells to doxorubicin via the PI3K/AKT/mTOR signaling pathway

(2019) Zhixiang Li et al.   Experimental and Therapeutic Medicine

Comparison of the Effects of Fucoidans on the Cell Viability of Tumor and Non-Tumor Cell Lines

(2019) Bittkau et al.   Marine Drugs

Rapamycin enhanced the antitumor effects of doxorubicin in myelogenous leukemia K562 cells by downregulating the mTOR/p70S6K pathway

(2019) Jie Li et al.   Oncology Letters

Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase

(2019) Jeonghun Han et al.   Journal of Oncology

Estrone-modified pH-sensitive glycol chitosan nanoparticles for drug delivery in breast cancer

(2018) Huan Yang et al.   Acta Biomaterialia

Doxorubicin resistance in breast cancer cells is mediated by extracellular matrix proteins

(2018) Carrie J. Lovitt et al.   BMC CANCER

In-vitro digestion of curcumin loaded chitosan-coated liposomes

(2018) Francesca Cuomo et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Characterization of a smart pH-cleavable PEG polymer towards the development of dual pH-sensitive liposomes

(2018) Manju Kanamala et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Treatment with DHA Modifies the Response of MDA-MB-231 Breast Cancer Cells and Tumors from nu/nu Mice to Doxorubicin through Apoptosis and Cell Cycle Arrest

(2018) Marnie Newell et al.   JOURNAL OF NUTRITION

Chitosan-coated liposomes loaded with butyric acid demonstrate anticancer and anti-inflammatory activity in human hepatoma HepG2 cells

(2018) Vincenzo Quagliariello et al.   ONCOLOGY REPORTS

pH-Sensitive PEGylated liposomes for delivery of an acidic dinitrobenzamide mustard prodrug: Pathways of internalization, cellular trafficking and cytotoxicity to cancer cells

(2017) Mimi M. Yang et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Nanostructured Lipid Carrier Co-loaded with Doxorubicin and Docosahexaenoic Acid as a Theranostic Agent: Evaluation of Biodistribution and Antitumor Activity in Experimental Model

(2017) Renata S. Fernandes et al.   MOLECULAR IMAGING AND BIOLOGY

ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis

(2017) Adela Madrid-Paredes et al.   SURGICAL ONCOLOGY-OXFORD

Establishment and characterization of a triple negative basal-like breast cancer cell line with multi-drug resistance

(2017) Sergei Boichuk et al.   Oncology Letters

Late cardiac effects of chemotherapy in breast cancer survivors treated with adjuvant doxorubicin: 10-year follow-up

(2016) G. Murtagh et al.   BREAST CANCER RESEARCH AND TREATMENT

Biweekly Pegylated Liposomal Doxorubicin (Caelyx) in Heavily Pretreated Metastatic Breast Cancer: A Phase 2 Study

(2016) Christian F. Jehn et al.   Clinical Breast Cancer

Docosahexaenoic acid liposomes for targeting chronic inflammatory diseases and cancer: an in vitro assessment

(2016) Amr Alaarg et al.   International Journal of Nanomedicine

Marine-Based Nutraceuticals: An Innovative Trend in the Food and Supplement Industries

(2015) Hafiz Suleria et al.   Marine Drugs

A pH-Responsive Drug-Delivery Platform Based on Glycol Chitosan-Coated Liposomes

(2015) Lesan Yan et al.   Small

Preparation of a liposomal delivery system and its in vitro release of rapamycin

(2015) ZHI-LIN MIAO et al.   Experimental and Therapeutic Medicine

Molecular weight dependence of structure and properties of chitosan oligomers

(2015) Meng Tian et al.   RSC Advances

Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer

(2014) Wenbing Dai et al.   BIOMATERIALS

Layer-by-layer assembly of chitosan stabilized multilayered liposomes for paclitaxel delivery

(2014) Meng-Xia Chen et al.   CARBOHYDRATE POLYMERS

Doxorubicin and Lapatinib Combination Nanomedicine for Treating Resistant Breast Cancer

(2014) Huiyuan Wang et al.   MOLECULAR PHARMACEUTICS

Resveratrol reverses multidrug resistance in human breast cancer doxorubicin-resistant cells

(2014) FANG HUANG et al.   Experimental and Therapeutic Medicine

Chitosan-Based Nanocarriers with pH and Light Dual Response for Anticancer Drug Delivery

(2013) Lili Meng et al.   BIOMACROMOLECULES

Tumor extracellular acidity-activated nanoparticles as drug delivery systems for enhanced cancer therapy

(2013) Jin-Zhi Du et al.   BIOTECHNOLOGY ADVANCES

The Regulation of Cell Size

(2013) Alison C. Lloyd   CELL

Doxorubicin/cyclophosphamide with concurrent versus sequential docetaxel as neoadjuvant treatment in patients with breast cancer

(2013) B.E.P.J. Vriens et al.   EUROPEAN JOURNAL OF CANCER

Generation and Characterisation of Cisplatin-Resistant Non-Small Cell Lung Cancer Cell Lines Displaying a Stem-Like Signature

(2013) Martin P. Barr et al.   PLoS One